For KM survival analysis (Fig. 6B–E), the low expression of COL15A1 represents a poor prognosis in THCA and LIHC, while in ACC and PRAD, the low expression of COL15A1 means a longer survival time. The gene discussed is COL15A1; the disease is prostate adenocarcinoma.